Oral cromoglycate: its value in the treatment of adverse reactions to foods.
Thirty-two patients who reacted adversely to foods were given oral cromoglycate and placebo separately for two periods of seven days each. Adverse reactions were prevented by cromoglycate alone in 24. The symptoms responding to cromoglycate affected not only the gastrointestinal tract but also the skeletal, vascular and nervous systems.
D002648:Child; D003424:Crohn Disease / Q000188:drug therapy; D004205:Cromolyn Sodium / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005512:Food Hypersensitivity / Q000188:drug therapy*; D006801:Humans; D007428:Intradermal Tests; D010919:Placebos; D011852:Radioallergosorbent Test; D012882:Skin Tests
D010919:Placebos; D004205:Cromolyn Sodium